Not Yet RecruitingPhase 2ACTRN12609001043224

Management of Refeeding Syndrome in Critical Illness: An Australasian Society of Parenteral and Enteral Nutrition (AuSPEN) Endorsed Multi-centre Phase II Randomised Controlled Trial.

In Critically Ill patients with Refeeding-related Hypophosphataemia, does energy restricted nutritional support compared with Standard/Usual care affect Intensive Care Unit (ICU) free days. A Phase II multi-centre randomised controlled trial.


Sponsor

National Health and Medical Research Council (NHMRC)

Enrollment

348 participants

Start Date

Jan 1, 2010

Study Type

Interventional

Conditions


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Protocol directed and energy restricted nutritional support during management of refeeding-related hypophosphataemia. Protocol currently under development by management committee and will be based on

Protocol directed and energy restricted nutritional support during management of refeeding-related hypophosphataemia. Protocol currently under development by management committee and will be based on review of best available evidence.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12609001043224